查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1974024

CRISPR市場分析及至2035年預測：按類型、產品、服務、技術、應用、最終用戶、組件、功能和解決方案分類

CRISPR Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Functionality, Solutions
出版日期: | 出版商: Global Insight Services | 英文 300 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計CRISPR市場規模將從2024年的37億美元成長到2034年的197億美元，複合年成長率約為18.2%。 CRISPR市場涵蓋與CRISPR-Cas9基因編輯相關的技術和服務，並在基因組學、農業和治療領域提供創新應用。精準醫療、作物改良和生物技術研究的進步是推動該市場成長的主要因素。研發投入的增加和倫理考量正在塑造市場格局，而監管合規和對智慧財產權的重視則影響市場動態和擴張。

受基因編輯技術進步以及在醫療保健和農業領域應用不斷拓展的推動，CRISPR市場正經歷強勁成長。在這充滿活力的市場環境中，治療領域憑藉其在治療遺傳疾病和癌症方面的創新潛力，已成為成長最快的細分市場。農業領域也緊隨其後，利用CRISPR技術提高作物品質和增強抗蟲害能力，進而應對全球糧食安全挑戰。在各個細分市場中，體內療法發揮主導作用，展現出在體內直接提供精準基因編輯解決方案的巨大潛力。體外應用也正在蓬勃發展，尤其是在細胞療法和再生醫學領域，凸顯了其變革性潛力。研發活動依然活躍，對CRISPR文庫和篩檢工具的投資正在推動創新。隨著倫理考量和法規結構的不斷完善，CRISPR市場可望取得更多突破，並正逐步成為生物技術革命的核心力量。

市場區隔
類型 基因組編輯、基因靜默、基因擴增
產品 CRISPR試劑盒、CRISPR文庫、CRISPR試劑、CRISPR質體
服務 客製化 CRISPR 服務、基因篩檢、細胞株設計
科技 CRISPR-Cas9、CRISPR-Cas12、CRISPR-Cas13
目的 生物醫學研究、農業生物技術、工業生物技術、藥物研發、診斷、治療、基因治療
最終用戶 製藥公司、生技公司、研究機構、學術機構、受託研究機構
成分 引導RNA、Cas酶、供體DNA模板
功能 基因敲除、基因敲入、基因表現調控
解決方案 現成解決方案，客製化解決方案

市場概況：

CRISPR市場呈現出動態變化的格局，包括市場佔有率分佈、定價策略以及新產品推出數量的激增。人們對基因編輯日益成長的興趣催生了激烈的競爭環境，各公司不斷創新以爭取市場佔有率。定價策略的驅動力在於平衡價格可負擔性和最尖端科技。近期發表的新產品在準確性和效率方面均有顯著提升，吸引了許多科學研究和治療應用。這一趨勢凸顯了市場致力於滿足多元化科學需求的努力。 CRISPR市場競爭異常激烈，主要企業透過策略聯盟和技術創新爭奪主導。北美和歐洲的法規結構在塑造市場走向、確保安全性和有效性方面發揮著至關重要的作用。亞太地區的新興市場在扶持政策和資金投入的推動下正蓬勃發展。不斷變化的監管環境影響企業的市場准入和擴大策略。競爭標竿分析凸顯了合規性、創新和策略聯盟在維持市場領先地位的重要性。

主要趨勢和促進因素：

由於基因編輯技術的進步和研究活動的日益活躍，CRISPR市場正在快速擴張。其主要趨勢包括農業領域應用的不斷拓展，CRISPR正被用於培育抗病作物並提高產量。在醫療保健領域，CRISPR正在革新遺傳疾病的治療方式，提供精準高效的解決方案。生技投資的增加也是推動市場成長的重要因素，各公司正積極探索CRISPR技術的創新應用。監管支持和有利的政府政策也促進了市場成長。此外，學術機構與生技公司之間的合作正在加速研發進程。在個人化醫療領域，CRISPR擁有巨大的潛力，能夠實現根據個體基因譜量身定做的治療方案。人們對基於CRISPR的診斷技術也越來越感興趣，期望能夠快速且準確地檢測疾病。隨著倫理挑戰的逐步解決，CRISPR市場憑藉其變革各領域的潛力，預計將持續成長。

壓制與挑戰：

CRISPR市場目前面臨諸多限制和挑戰。其中一個突出的限制因素是基因編輯相關的倫理問題，這阻礙了監管部門的核准和社會的接受度。潛在的非預期基因效應加劇了這些擔憂，因此需要嚴格的監測和謹慎的應用。另一個挑戰是CRISPR技術的高成本，這可能成為小規模研究機構和發展中地區的障礙。這種經濟壁壘限制了技術的普及，並減緩了創新的步伐。此外，圍繞CRISPR專利的智慧財產權糾紛造成了法律上的複雜性，並可能阻礙合作研究。該市場也面臨一些技術挑戰，例如脫靶效應，這會影響基因編輯的精確性。這些技術障礙需要大量的研發工作來確保安全性和有效性。最後，CRISPR技術的快速發展要求研究人員不斷接受教育和培訓，這使得他們難以跟上技術進步的步伐。

目錄

第1章：摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 基因組編輯
    • 基因靜默
    • 基因擴增
  • 市場規模及預測：依產品分類
    • CRISPR試劑盒
    • CRISPR 文庫
    • CRISPR試劑
    • CRISPR質體
  • 市場規模及預測：依服務分類
    • 客製化CRISPR服務
    • 基因篩檢
    • 細胞株工程
  • 市場規模及預測：依技術分類
    • CRISPR-Cas9
    • CRISPR-Cas12
    • CRISPR-Cas13
  • 市場規模及預測：依應用領域分類
    • 生物醫學研究
    • 農業生物技術
    • 工業生物技術
    • 藥物研發
    • 診斷
    • 治療
    • 基因治療
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 生技公司
    • 研究機構
    • 學術機構
    • 受託研究機構
  • 市場規模及預測：依組件分類
    • 引導RNA
    • CAS酶
    • 供體DNA模板
  • 市場規模及預測：依功能分類
    • 基因敲除
    • 基因敲入
    • 基因調控
  • 市場規模及預測：依解決方案分類
    • 現成的解決方案
    • 客製化解決方案

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Editas Medicine
  • CRISPR Therapeutics
  • Intellia Therapeutics
  • Caribou Biosciences
  • Mammoth Biosciences
  • Beam Therapeutics
  • Synthego
  • Inscripta
  • Cellecta
  • Horizon Discovery
  • ToolGen
  • Egenesis
  • Graphite Bio
  • Locus Biosciences
  • Poseida Therapeutics

第9章 關於我們

簡介目錄
Product Code: GIS33751

CRISPR Market is anticipated to expand from $3.7 billion in 2024 to $19.7 billion by 2034, growing at a CAGR of approximately 18.2%. The CRISPR Market encompasses technologies and services related to CRISPR-Cas9 gene editing, offering revolutionary applications in genomics, agriculture, and therapeutics. This market is driven by advancements in precision medicine, crop improvement, and biotechnological research. Increasing investment in R&D and ethical considerations shape the landscape, with a focus on regulatory compliance and intellectual property rights influencing market dynamics and expansion.

The CRISPR market is experiencing robust growth, fueled by advancements in gene-editing technologies and increasing applications in healthcare and agriculture. Within this dynamic landscape, the therapeutics segment emerges as the top-performing sub-segment, driven by its potential to revolutionize treatment for genetic disorders and cancers. The agricultural sector follows closely, leveraging CRISPR for crop improvement and pest resistance, addressing global food security challenges. Among the sub-segments, in vivo therapeutics leads, showcasing significant promise in delivering precise gene-editing solutions directly within the body. Ex vivo applications are gaining momentum, particularly in cell therapy and regenerative medicine, underscoring their transformative potential. The research and development sector continues to thrive, with investments in CRISPR libraries and screening tools fueling innovation. As ethical considerations and regulatory frameworks evolve, the CRISPR market anticipates further breakthroughs, positioning it as a pivotal force in the biotechnological revolution.

Market Segmentation
TypeGenome Editing, Gene Silencing, Gene Amplification
ProductCRISPR Kits, CRISPR Libraries, CRISPR Reagents, CRISPR Plasmids
ServicesCustom CRISPR Services, Genetic Screening, Cell Line Engineering
TechnologyCRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13
ApplicationBiomedical Research, Agricultural Biotechnology, Industrial Biotechnology, Drug Development, Diagnostics, Therapeutics, Gene Therapy
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Academic Institutions, Contract Research Organizations
ComponentGuide RNA, Cas Enzymes, Donor DNA Templates
FunctionalityGene Knockout, Gene Knock-in, Gene Regulation
SolutionsOff-the-shelf Solutions, Customized Solutions

Market Snapshot:

The CRISPR market is characterized by a dynamic landscape of market share distribution, pricing strategies, and a surge in new product launches. The growing interest in gene editing has led to a competitive environment where companies are continuously innovating to capture market share. Pricing strategies are influenced by the need to balance affordability with cutting-edge technology. Recent product launches highlight advancements in precision and efficiency, appealing to both research and therapeutic applications. This trend underscores the market's commitment to addressing diverse scientific needs. Competition within the CRISPR market is intense, with key players vying for dominance through strategic partnerships and technological innovation. Regulatory frameworks in North America and Europe play a crucial role in shaping market trajectories, ensuring safety and efficacy. Emerging markets in Asia-Pacific are gaining momentum, driven by supportive policies and increased funding. As regulatory landscapes evolve, they impact market entry and expansion strategies. The competitive benchmarking highlights the importance of compliance, innovation, and strategic collaborations in sustaining market leadership.

Geographical Overview:

The CRISPR market is witnessing remarkable growth across various regions, each exhibiting unique dynamics. North America leads the market due to robust research initiatives and substantial funding from both public and private sectors. The region's strong biotechnology infrastructure and supportive regulatory environment further bolster its dominance. Europe follows closely, driven by significant investments in genetic research and a favorable regulatory framework that encourages innovation. Asia Pacific is emerging as a lucrative growth pocket, fueled by increasing governmental support and rising investments in biotechnology. Countries like China and Japan are at the forefront, leveraging their technological prowess to advance CRISPR applications. In Latin America, Brazil is making strides, with growing research activities and collaborations enhancing its market potential. The Middle East & Africa are gradually recognizing CRISPR's potential, with countries like South Africa investing in genetic research to drive future growth.

Key Trends and Drivers:

The CRISPR market is rapidly expanding, driven by advancements in gene-editing technologies and increasing research activities. Key trends include the growing application of CRISPR in agriculture, where it is used to develop disease-resistant crops and improve yield. In the healthcare sector, CRISPR is revolutionizing treatments for genetic disorders, offering precise and efficient solutions. The rise in biotechnology investments is a significant driver, with companies seeking innovative applications of CRISPR technology. Regulatory support and favorable government policies are also boosting market growth. Additionally, collaborations between academic institutions and biotech firms are accelerating research and development efforts. Opportunities abound in personalized medicine, where CRISPR can tailor treatments to individual genetic profiles. The market is also witnessing increased interest in CRISPR-based diagnostics, which promise rapid and accurate disease detection. As ethical considerations are addressed, the CRISPR market is poised for sustained growth, driven by its transformative potential across various sectors.

Restraints and Challenges:

The CRISPR market is currently navigating a landscape of significant restraints and challenges. A prominent restraint is the ethical concerns surrounding gene editing, which hinder regulatory approvals and public acceptance. These concerns are amplified by the potential for unintended genetic consequences, necessitating rigorous oversight and cautious application. Another challenge is the high cost associated with CRISPR technology, which can be prohibitive for small-scale research institutions and developing regions. This financial barrier restricts access and slows the pace of innovation. Additionally, intellectual property disputes over CRISPR patents create legal complexities and can impede collaborative research efforts. The market also faces technical challenges, such as off-target effects, which compromise the precision of gene editing. These technical hurdles demand extensive research and development to ensure safety and efficacy. Lastly, the rapid evolution of CRISPR technology necessitates continuous education and training for researchers, posing a challenge in keeping pace with advancements.

Key Players:

Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences, Mammoth Biosciences, Beam Therapeutics, Synthego, Inscripta, Cellecta, Horizon Discovery, ToolGen, Egenesis, Graphite Bio, Locus Biosciences, Poseida Therapeutics

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Genome Editing
    • 4.1.2 Gene Silencing
    • 4.1.3 Gene Amplification
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 CRISPR Kits
    • 4.2.2 CRISPR Libraries
    • 4.2.3 CRISPR Reagents
    • 4.2.4 CRISPR Plasmids
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Custom CRISPR Services
    • 4.3.2 Genetic Screening
    • 4.3.3 Cell Line Engineering
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 CRISPR-Cas9
    • 4.4.2 CRISPR-Cas12
    • 4.4.3 CRISPR-Cas13
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Biomedical Research
    • 4.5.2 Agricultural Biotechnology
    • 4.5.3 Industrial Biotechnology
    • 4.5.4 Drug Development
    • 4.5.5 Diagnostics
    • 4.5.6 Therapeutics
    • 4.5.7 Gene Therapy
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Pharmaceutical Companies
    • 4.6.2 Biotechnology Companies
    • 4.6.3 Research Institutes
    • 4.6.4 Academic Institutions
    • 4.6.5 Contract Research Organizations
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Guide RNA
    • 4.7.2 Cas Enzymes
    • 4.7.3 Donor DNA Templates
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Gene Knockout
    • 4.8.2 Gene Knock-in
    • 4.8.3 Gene Regulation
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Off-the-shelf Solutions
    • 4.9.2 Customized Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Functionality
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Functionality
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Functionality
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Functionality
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Functionality
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Functionality
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Functionality
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Functionality
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Functionality
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Functionality
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Functionality
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Functionality
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Functionality
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Functionality
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Functionality
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Functionality
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Functionality
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Functionality
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Functionality
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Functionality
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Functionality
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Functionality
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Functionality
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Functionality
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Editas Medicine
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 CRISPR Therapeutics
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Intellia Therapeutics
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Caribou Biosciences
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Mammoth Biosciences
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Beam Therapeutics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Synthego
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Inscripta
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Cellecta
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Horizon Discovery
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 ToolGen
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Egenesis
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Graphite Bio
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Locus Biosciences
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Poseida Therapeutics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us